UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Demand for medical arts rises amid COVID-19 crisis
by Kim Eun-young
2020-04-10 17:30
Government begins to discuss ‘life quarantine system’
by Kwak Sung-sun
2020-04-10 17:03
SNUH’s new AI model assesses cardiovascular death risk
by Shim Hyun-tai
2020-04-10 16:58
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
by Kim Yun-mi
2020-04-10 15:36
[New York Scene] ‘Doctors with mild COVID-19 symptoms have to see patients in New York’
by Song Soo-youn
2020-04-10 15:34
라인
Korea considers testing pooled samples for vulnerable groups
by Kwak Sung-sun
2020-04-10 15:30
‘Electric stimulation of relevant hippocampus enhances associative memory’
by Shim Hyun-tai
2020-04-10 15:29
No mutation occurred in COVID-19 virus in Korea
by Kwak Sung-sun
2020-04-10 10:51
Yongin Severance Hospital introduces automated blood test
by Shim Hyun-tai
2020-04-09 16:57
‘Korea needs more hospital beds for severe patients’
by Song Soo-youn
2020-04-09 16:43
라인
Immunologic classification predicts effect of immunotherapies in OPC
by Kim Yoon-mi
2020-04-09 16:35
New horizon opens for targeted therapy of metastatic brain tumor
by Choi Gwang-seok
2020-04-09 16:31
Fewest new virus cases reported since late February
by Shim Hyun-tai
2020-04-09 14:42
Korean diagnostics industry to enjoy unprecedented boom
by Jeong Sae-im
2020-04-09 14:30
Executive salaries highest at Samsung Biologics, Celltrion
by Jeong Sae-im
2020-04-09 11:13
라인
Solgent picked as supplier for US agency
by Shim Hyun-tai
2020-04-08 18:31
No Korean firms have entered trials to test COVID-19 drug candidates
by Jeong Sae-im
2020-04-08 16:15
SNUH team finds causal gene of inherited retinal disorder
by Shim Hyun-tai
2020-04-08 15:37
Stringent social distancing curbs new virus cases to around 50
by Shim Hyun-tai
2020-04-08 15:11
COVID-19 attacks New York harder than 9/11
by Song Soo-youn
2020-04-08 14:40
-
이전
41
42
43
44
45
46
47
48
49
50
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top